Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2005 | 09-2004 | 09-2003 | 09-2002 | 09-2001 | |
| Sales | 2,445 | 3,756 | 4,778 | 5,711 | 5,974 |
| Cost of Goods | 204 | 117 | 200 | 214 | 204 |
| Gross Profit | 2,241 | 3,639 | 4,578 | 5,497 | 5,769 |
| Operating Expenses | 15,579 | 8,421 | 6,429 | 5,956 | 5,494 |
| Operating Income | -13,134 | -4,665 | -1,651 | -244 | 480 |
| Other Income | 419 | 170 | 2,394 | -1,462 | -4,284 |
| Pre-tax Income | -12,715 | -4,495 | 742 | -1,706 | -3,804 |
| Income Tax | N/A | N/A | -125 | N/A | 25 |
| Net Income Continuous | -12,715 | -4,495 | 867 | -1,706 | -3,829 |
| Net Income | $-12,715 | $-4,495 | $867 | $-1,706 | $-3,829 |
| EPS Basic Total Ops | -1.47 | -0.57 | 0.13 | -0.26 | -0.57 |
| EPS Basic Continuous Ops | -1.47 | -0.58 | 0.13 | -0.26 | -0.57 |
| EPS Diluted Total Ops | -1.47 | -0.57 | 0.12 | -0.26 | -0.57 |
| EPS Diluted Continuous Ops | -1.47 | -0.58 | 0.12 | -0.26 | -0.57 |
| EBITDA(a) | $-12,701 | $-4,245 | $-1,446 | $-156 | $741 |